These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. Clerico A; Caprioli R; Del Ry S; Giannessi D J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728 [TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578 [TBL] [Abstract][Full Text] [Related]
11. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996 [TBL] [Abstract][Full Text] [Related]
12. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Wilkins MR; Wood JA; Adu D; Lote CJ; Kendall MJ; Michael J Clin Sci (Lond); 1986 Aug; 71(2):157-60. PubMed ID: 2941209 [TBL] [Abstract][Full Text] [Related]
13. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Haug C; Metzele A; Kochs M; Hombach V; Grünert A Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764 [TBL] [Abstract][Full Text] [Related]
14. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213 [TBL] [Abstract][Full Text] [Related]
15. Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. Tanaka T; Hasegawa K; Fujita M; Tamaki SI; Yamazato A; Kihara Y; Nohara R; Sasayama S J Am Coll Cardiol; 1998 Feb; 31(2):399-403. PubMed ID: 9462585 [TBL] [Abstract][Full Text] [Related]
16. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942 [TBL] [Abstract][Full Text] [Related]
17. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831 [TBL] [Abstract][Full Text] [Related]
18. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure. Walker RG; Swainson CP; Yandle TG; Nicholls MG; Espiner EA Clin Sci (Lond); 1987 Jan; 72(1):19-24. PubMed ID: 2948753 [TBL] [Abstract][Full Text] [Related]
19. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure. Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM Clin Sci (Lond); 1997 Feb; 92(2):159-65. PubMed ID: 9059317 [TBL] [Abstract][Full Text] [Related]